A retrospective study of CHEMOSAT in patients with non-resectable hepatic metastases from uveal melanoma

Trial Profile

A retrospective study of CHEMOSAT in patients with non-resectable hepatic metastases from uveal melanoma

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2015

At a glance

  • Drugs Melphalan (Primary)
  • Indications Uveal melanoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Nov 2015 New trial record
    • 02 Nov 2015 Results published in Delcath System media release.
    • 02 Nov 2015 Results presented at Delcath Systems media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top